Socioeconomic correlates of generalized anxiety disorder and major depression in primary care: The GADIS II study (Generalized Anxiety and Depression Impact Survey II)

Depression and Anxiety

Volumn 25, Issue 6, 2008, Pages 506-513

  Ansseau, Marc ^a   Fischler, Benjamin ^b   Dierick, Michel ^c   Albert, Adelin ^d   Leyman, Sophie ^e   Mignon, Annick ^e  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^c Psychiatric Hospital St Camillus   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e PFIZER INC   (United States)

Author keywords

Generalized anxiety disorder; Major depression; Primary care

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; BELGIUM; EDUCATION; FEMALE; GENERALIZED ANXIETY DISORDER; HEALTH SURVEY; HUMAN; LUXEMBOURG; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RATING SCALE; SEX RATIO; SHEEHAN DISABILITY SCALE; SOCIOECONOMICS; UNEMPLOYMENT;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; BELGIUM; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; FAMILY PRACTICE; FEMALE; HEALTH SURVEYS; HUMANS; LUXEMBOURG; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PSYCHOTHERAPY; SOCIOECONOMIC FACTORS;

EID: 46049091380     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20306     Document Type: Article

References (32)

1. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA, ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project. 2004. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 109 (suppl. 420):55-64.
2. Ansseau M, Dierick M, Buntinckx F, Cnockaert P, De Smedt J, Van Den Haute M, Vander Mijnsbrugge D. 2004. High prevalence of mental disorders in primary care. J Aff Dis 78:49-55.
3. Ansseau M, Fischler B, Dierick M, Mignon A, Leyman S. 2005. Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: The GADIS study. Eur Psychiatry. 20:229-235.
4. Belgian Gouvernment. Department of Federal Statistics. 2005.
5. Bruffaerts R, Bonnewyn A, Van Oyen H. 2005. Consommation de médicaments psychotropes dans la population belge: résultats de l'European Study of the Epidemiology of Mental Disorders (ESEMeD). Rev Med Liege. 60:181-188.
6. Feline A, Le Goc I. 1985. Les Benzodiazépines: prescription, consommation, addiction. Semaine Hôpitaux 61:3172-3175.
7. Hunt C, Issakidis C, Andrews G. 2002. DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and well-being. Psychol Med 4:649-659.
8. Kessler RC. 2002. Evidence that generalized anxiety disorder is an independent disorder. In: Nutt D, Rickels K, Stein DJ, editors. Generalized anxiety disorder: symptomatology, pathogenesis and management. London: Martin Dunitz Ltd. pp 3-10.
9. Kessler RC, Berglund P, Demler O, Jin R, Walters EE. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62:590-592.
10. Kessler RC, Du Pont RL, Berglun P, Wittchen HU. 1999. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry. 156:1915-1923.
11. Legrain M, Lecomte T 1997. La consommation des psychotropes en France et dans quelques pays européens. Bull Acad Natl Med. 181:1073-1084.
12. Leon AC, Olfson M, Weissman MM, Portera L, Fireman BH, Blacklow RS, Hoven C, Broadhead WE. 1996. Brief screens for mental disorders in primary care. J Gen Intern Med. 11:426-430.
13. Lieb R, Becker E, Altamura C. 2005. The epidemiology of generalized anxiety disorder in Europe. Eur Neuropsychopharmacol. 15:445-452.
14. Lorant V, Deliège D, Eaton W, Robert A, Philippot P, Ansseau M. 2003. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol 157:98-112.
15. Maier W, Gansicke M, Freiberger HJ, Linz M, Heun R, Lecrubier Y. 2000. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity ? Acta Psychiatrica Scand. 101:29-36.
16. Ohayon MM, Lader MH. 2002. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. 63:817-825.
17. Olfson M, Fireman B, Weissman MM. et al. 1997. Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry. 154:1734-1740.
18. Ormel J, Von Korff M, Ustun B, Pini S, Korten A, Oldehinkel T. 1994. Common mental disorders and disability accross culture: results from the WHO collaborative study on psychological problems in general health care. JAMA. 272:1741-1748.
19. Pelissolo A, Boyer P, Lepine JP, Bisserbe JC. 1996. Epidémiologie de la consommation des anxiolytiques et des hypnotiques en France et dans le monde. Encephale. 22:187-196.
20. Reggers J, Ansseau M. 1999. Lifetime prevalence of DSM-IV psychiatric disorders in the Liège study: preliminary results. Abstracts of the VIII Congress of the International Federation of Psychiatric Epidemiology.
21. Sartorius N, Ustun TB, Lecrubier Y. 1996. Depression comorbid with anxiety/Results from the WHO study on the psychological disorders in primary health care. Br J Psychiatry. 168 (suppl 30):38-43.
22. Schonfeld WH, Verboncoeur CJ, Fifer SK, Lipschutz RC, Lubeck DP, Buesching DP. 1997. The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder. J Aff Disord. 43:105-119.
23. Scientific Institute of Public Health. Health Survey by interviews, Belgium, 2004.
24. Sheehan DV, Harnett-Sheehan K, Raj BA. 1996. The measurement of disability. Int Clin Psychopharmacol. 11 (suppl 3):89-95.
25. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59 (Suppl 20):22-33.
26. Souêtre E, Lozet H, Cimarosti I, Martin P, Chignon JM, Adès J, Tignol J, Darcourt G. 1994. Cost of anxiety disorders: impact of comorbidity. J Psychosom Res. 38:151-160.
27. Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JB, DeGruy FV 3rd, Brody D, Davies M. 1995. Health-related quality of life in primary care patients with mental disorders. JAMA 274: 1511-1517.
28. Spitzer RL, Williams JB, Kroenke K, Linzer M, VerloindeGruy F III, Hahn SR, Brody D, Johnson JG. 1994. Utility of a new procedure for diagnosing mental disorders in primary care. JAMA. 272:1749-1756.
29. Ustün TB, Sartorius N. Eds. 1995. Mental illness in general health care: an international study. Chichester: John Wiley.
30. Weiller E, Bisserbe JC, Maier W, Lecrubier Y. 1998. Prevalence and recognition of anxiety syndromes in five European primary care settings: a report from the WHO study on Psychological problems in General Health care. Br J Psychiatry. 173 (Suppl 34): 18-23.
31. Wittchen H-U, Zhao S, Kessler RC, Eaton WW. 1994. DSM-III-R generalized anxiety disorder in the national comorbidity survey. Arch Gen Psychiatry 355-364.
32. Wittchen H-U. 2001. GAD-P Studie. Bundesweite Studie "Generalisierte angst und depression im primaeraerztlichen bereich". Fortschritte Medizin 119 (Sonderheft 1):1-49.